Zai lab limited

Major-Pharmaceuticals

ZLAB


Building 1, Jinchuang Plaza
Shanghai , 201210

Executive/
Director

Price

  • Last Close
  • $ 28
    $ -0.27 -0.96 %
    Dec 5, 2024
  • 52-Week High/Low
  • $30.58 - $13.73
  • YTD
  • 2.5%

  • Trading Volume
  • 11,979
  • Market Cap Full
  • $ 2.5B
  • Shares Outstanding
  • 88.6M
    Feb 26, 2021
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - 0.6% 27.1% -5% -1.4% -30% 8.3% -41.4%
Q2 - - - 9.5% 17.3% 4% 32.7% -21.2% -16.6% -4.1%
Q3 - - -3.3% -17.2% -7.4% 8% -39.8% -1.4% -12.3% -
Q4 - - -19.6% 18.2% 28.2% 62.7% -41% -10.2% 14.7% -
J F M A M J J A S O N D
2024 -21.1% -2.7% -23.6% 0.1% - - - - - - - -
2023 37.3% -11.8% -10.5% 5.2% -7.1% -14.7% 8.4% -15.3% -4.6% 3.7% 8.3% 0.2%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%9%80%223%-54%-51%-11%2%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - - - - - - -0.51
Q2 - - - - - - - - -1.25
Q3 - - - - - - - - -0.71
Q4 - - - - -3.03 -3.46 -7.58 -0.65 -
A 0 0 0 0 -3 -0.4 -0.8 -0.5 -2.47

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2021
Mar - - 88.6
Jun - - -
Sep - - -
Dec 58.4 68.4 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 2.3 2.7 1.3 0.7 -
Fixed Asset Turnover 3.2 2.3 1.5 0.5 -
Total Asset Turnover 0.2 0.1 - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -10.4 -175 9.2 25.4 47.3
Equity multiplier 0.1 - - 0.1 0.1